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CHAPTER I 
Introduction 
 
  Attention Deficit/Hyperactivity Disorder (ADHD) is the most common psychiatric illness 
in children (Szymanski & Zolotor, 2001). The accepted treatment is a combination of stimulant 
medication and behavioral therapy with frequent follow-up office visits (Stockl, Hughes, Jarrar, 
Secnik, & Perwien, 2003; Szymanski & Zolotor, 2001). However, a surprising percentage of 
children with ADHD are being treated with medication alone without adequate follow-up 
(Rushton, Fant, & Clark, 2004). The research discussed below indicates that primary care 
physicians (PCPs) are able to diagnosis this illness; however, they are not utilizing the 
appropriate treatment options available for children. To further complicate matters, this is an 
illness that will not typically go away with time. Eliott (2002) showed up to 60% of children with 
ADHD progress into adulthood and live with the disruptive symptoms of ADHD that alter their 
daily activities. That percentage, if accurate, is alarming. ADHD is a disorder that needs to be 
successfully managed in childhood to reduce the number of symptomatic adults.  
However, management of ADHD has become complicated in today’s society due to negative 
perceptions about the disease (Kanapaux, 2002) and the media’s focus on unjustifiable 
accusations towards stimulant medication. Though stimulant medication alone is effective 
treatment in most cases (Szymanski & Zolotor, 2001), a more involved, multimodal treatment 
plan is needed when noting the progression of this illness into adulthood. Kanapaux (2004) 
found that most children diagnosed with ADHD never see a psychiatrist for treatment. This 
seems unusual since ADHD is a behavioral disease that manifests in many settings and affects 
the entire family. One would think the benefit from behavioral therapy in combination with 
medication would be an ideal treatment.    9 
Statement of Purpose 
The purpose of this study was to examine and compare the attitudes and knowledge about 
behavioral therapy in the treatment of ADHD between family practice physicians and 
psychiatrists. 
Statement of the Problem 
The accepted treatment recommendation by the AAP for ADHD is a combination of 
medication and psychotherapy/behavioral therapy.  However, the majority of children with 
ADHD are being treated with medication alone. Testing attitudes and knowledge about 
behavioral therapy in the treatment of ADHD among different primary care professionals might 
uncover why current recommended treatment is not being applied to many patients with ADHD. 
Assumptions 
1)  This study assumed that the problems that prevent health care professionals from 
delivering the gold standard of treatment for ADHD patients are options listed on the 
questionnaire. These options were based on previous research and literature listed in the 
literature review. However, there may be the possibility that some options have not yet 
been uncovered and no literature is yet available. Furthermore, the survey was developed 
in a multiple-choice, anonymous organization; therefore, there is no way for the 
participants to communicate alternative possibilities that restrict the treatment for ADHD 
from the standard of care. 
2)  It was assumed that the optimal groups for comparison in this study were family care 
physicians and psychiatrists. This was based on the ideology that family care physicians 
are the health professionals that are most likely to see ADHD patients initially for 
diagnosis and begin or maintain a treatment regimen. Psychiatrists were chosen as the    10 
comparative group because these health care professionals seemed most likely to support 
behavioral therapy and know the means necessary to obtain this therapy for ADHD 
patients, due to the nature of the psychiatry specialty. In a sense, it would seem 
psychiatrists should hold an innate bias toward behavioral therapy for ADHD, as is the 
recommended treatment. If there are obstacles in obtaining the recommended behavioral 
therapy, psychiatrists should be familiar with these obstacles, provided the obstacles were 
correctly stated on the questionnaire.  
3)  Since there was no pilot study done for this project, it was assumed that the overall 
method and evaluation process in this project were done in a valid manner. 
4)  In was assumed that participants in this study returned the questionnaires and answered 
the questions honestly to best of their knowledge, without outside aid of any kind. It was 
also assumed that the participants were family practice physicians or psychiatrists who 
have had experience in their designated fields, as opposed to students or other health care 
providers working with these professionals.   
Limitations 
1)  This study involved only health care professionals associated with the Medical University 
of Ohio and within the Northwest Ohio region. This sample of the population of health 
care professionals may hold certain ideals or bias about the treatment of ADHD based on 
training received from the Medical University of Ohio or ideals held within the 
Northwest Ohio regional community. Such ideals and bias could affect the outcome of 
this study, but may not represent ideals held in other surrounding organizations or 
communities. An effort to correct this limitation was made by dispersing surveys as 
widely and evenly as possible throughout the Northwest Ohio region.     11 
2)  The sampling in this study was limiting. Out of the one-hundred and sixteen surveys 
handed out, a total of forty-two were correctly returned for data analysis. This was a 
response rate of thirty-six percent. The low response rate might be a limiting factor in this 
research project and therefore, results from the data may not represent a larger population 
or even a larger sample of the population at hand. Efforts were made to increase response 
rates by redelivering the surveys to participants and encouraging them to complete and 
return the survey if they had not already done so. The distribution between the two 
groups (family practice physicians and psychiatrists) was fairly even and did not seem to 
be a limiting factor when the data from the two groups were compared and analyzed. Out 
of the forty-two returned surveys, sixty percent were family practice physicians and forty 
percent were psychiatrists.   
3)  The non-experimental design of this study provides some limitation in regards to the 
cause-and-effect relationship. Since there is no treatment given to the participants, nor 
was there randomization of the two groups, only observations and comparisons between 
the two groups were made. Therefore, deductions as to why certain results were obtained 
cannot and were not proven; only speculation and suggestions as to why results were 
obtained were discussed based on the analysis of data and review of literature. However, 
the observations made in this study may help fuel future research projects with different 
experimental designs able to ascertain why certain phenomena are occurring that this 
project could not prove.    
Hypotheses 
   Alternative: Psychiatrists will be more knowledgeable and have a more positive attitude 
towards the use of behavioral treatment for ADHD patients than family practice physicians.    12 
  Null: There will be no difference in attitude or knowledge about behavioral therapy in the 
treatment of ADHD patients between family practice physicians and psychiatrists.  
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CHAPTER II:  
Review of the Literature 
History and Background of ADHD 
Attention Deficit/Hyperactivity Disorder (ADHD) was first documented in 1846 by a 
physician named Heinrich Hoffman from Germany (Thome, 2004). The symptoms of ADHD 
were noted in a character called “Fidgety Philip” in a children’s book that Dr. Hoffman wrote 
called Struwwelpeter for his son. This character showed the first documented diagnosis of 
ADHD. Also in Thome’s 2004 article, he makes the argument that this book by Dr. Hoffman 
disproves the theory by critics that states ‘ADHD is an illness invented by modern times’. After 
all, Heinrich Hoffman founded the first mental hospital in Germany during the mid-eighteen 
hundreds according to Thome (2004). If Dr. Hoffman’s character “Fidgety Philip” truly 
represents a child or children that he has seen while practicing, than Thome’s argument seems to 
be true.  
ADHD was documented later in 1902 by a pediatrician named George Still. Still wrote 
about ADHD as a disorder of “lack of moral control”, mainly seen in young boys (Still, 1902). It 
wasn’t until the 1960’s, that ADHD was recognized and officially named Hyperactive Child 
Syndrome (MacMartin, 2000). The historical nature and recorded incidence of ADHD is 
important in this context because there has been a widespread misperception that ADHD is an 
illness that has been invented recently by the medical profession. This false perception, as well 
as others, has led to negative attitudes toward ADHD by both health care providers and public 
opinion.      
 
    14 
Negative Perceptions toward ADHD 
It seems that few topics in children’s health have generated as much public concern and 
negative stigma as ADHD. Kanapaux (2002) blames the negative perceptions of the disease on 
media outlets that worried communities in the 1990’s and 2000’s about children using schedule 
II drugs, though there was no evidence to suggest this regimen to be unsafe for children. This 
reference also states that there is an overall discomfort among people in the public towards 
putting children on any kind of regular medication for a “behavioral illness”, whether it is 
necessary or not.  Kanapaux (2002) goes on further to suggest another reason there are negative 
perceptions among health care providers (PCPs) towards ADHD may be because of the fear that 
parents want their children to be well-behaved at school and will often present in the office 
demanding medication for their children. Elliott (2002) agreed and added that some primary care 
physicians feel ADHD can often be a “self-diagnosed condition”. Because of this “self-
diagnosis”, PCPs feel uncomfortable prescribing a scheduled drug. From this data an assumption 
could be made that negative attitudes towards ADHD could be formed by PCPs because of the 
confusion as to whether a correct diagnosis was actually ever obtained for their ADHD patients 
or if the patient’s parents self-diagnosed their own child. Most parents probably believe ADHD 
is a behavioral disorder caused by high sugar intake/food additives, poor parenting, or even lack 
of physical activity (Parker, 2005). The organization called CHADD-Children and Adults with 
Attention Deficit Hyperactivity Disorder displayed an article in 2004 that provides evidence 
against those that theorize ADHD is caused by increased sugar intake or poor parenting. 
CHADD also dismissed the idea that ADHD is “not a real disorder” and has the sole goal of 
educating people about ADHD to avoid such misperceptions. However, negative attitudes and 
false knowledge still persists among the public, including health care providers.      15 
Etiology of ADHD 
In actuality the current, accepted etiology of ADHD is a neuro-psychiatric disorder in 
which 80% of cases have a genetic basis (Voeller, 2004). Elliot (2002) suggests ADHD is the 
result of a metabolic deficit that causes changes to the basal ganglia and corpus collosum 
symmetry—though MRI and CT scans are negative.  The Mayo Clinic Health Library (2005) 
lists four possible risk factors that contribute to the development of ADHD:  1) altered brain 
function due to changes in neural pathways or dopamine levels, 2) heredity, 3) maternal smoking 
or drug use that exposes the fetus to toxins, and 4) childhood exposure to lead or environmental 
toxins. Much research needs to be completed before the true factors causing ADHD can be 
determined.  
Symptoms and DSM-IV Diagnostic Criteria of ADHD 
There are no laboratory tests or imaging systems able to diagnose ADHD (Zolotor & 
Szymanski, 2001). However, the Diagnostic and Statistical Manual of Mental Disorders, 4
th ed. 
(DSM-IV) lists several symptoms under the diagnostic criteria for ADHD.  The hallmark 
symptom should be inattention and/or hyperactivity. The onset of these symptoms should be 
before the age of seven and these symptoms must be present in two or more settings. Also, 
symptoms should be present for six months or longer and be maladaptive or inconsistent with the 
patient’s normal developmental level. Since there are subtypes of ADHD (the inattentive type, 
the hyperactive/impulsive type, or a combination of the two), there are two lists of additional 
symptoms that patients must exhibit. For the inattentive type, patients must exhibit six of the 
following symptoms: fails to give close attention to details or makes careless mistakes, often has 
difficulty sustaining attention, often does not seem to listen when spoken to directly, often does 
not follow through on instructions and fails to finish tasks, often has difficulty organizing tasks    16 
and activities, often avoids or is reluctant to engage in tasks that require sustained mental effort, 
often loses things necessary for tasks, often easily distracted by extraneous stimuli, or is often 
forgetful in daily activities. For the hyperactive-impulsive type, patients must exhibit six of the 
following symptoms: often fidgets with hands or feet or squirms in seat, often leaves seat in 
classroom or in other situations, often runs about or climbs excessively in situations in which it is 
inappropriate, often has difficulty playing or engaging in leisure activities quietly, often “on the 
go” or often acts as if “driven by a motor”, often talks excessively, often blurts out answers 
before questions have been completed, often has difficulty awaiting turn, or often interrupts or 
intrudes on others. If a patient is diagnosed with a combination of subtypes, that patient should 
exhibit twelve symptoms, six from each list. 
Difficulties and Keys for the Accurate Diagnosis of ADHD 
  ADHD seems difficult to diagnose due to the subjective nature of the DSM-IV diagnostic 
criteria. Johnson (1997) and others found it necessary to diagnosis ADHD not only with an initial 
office visit, but also observe the patient in an outside setting. Kanapaux (2002) claims research 
supports that an accurate and reliable diagnosis can be made through the DSM-IV criteria, but a 
comprehensive psychiatric evaluation by a professional with expertise in ADHD is needed as 
well.   
 Although other disruptive behavioral disorders seem to mimic ADHD symptoms, Kim 
and Miklowitz (2002) also support the idea that an accurate diagnosis can be made using the 
DSM-IV criteria. If such a thorough evaluation is needed to diagnose ADHD, and Ruchton, Fant, 
and Clark (2004) found 77% of the surveyed PCPs were in fact familiar with diagnostic 
guidelines, it is surprising only 25.8% of these PCPs utilized all of the diagnostic components to 
evaluate their patients. Either the PCPs do not know the complete diagnostic criteria, there are    17 
underlying issues that prevent utilization of this criteria, or even though diagnostic criteria is 
known, is it difficult to recognize ADHD symptoms clinically because of a lack of experience. 
These issues warrant further investigation. 
Comorbidity and Differential Diagnoses associated with ADHD 
The accurate diagnosis of ADHD is often complicated due to existing comorbidity or 
other illnesses that mimic ADHD. Some comorbidities include: Oppositional Defiant Disorder, 
Conduct Disorder, Anxiety Disorder, Depression, Learning Disorders, or Tourette’s syndrome. 
In fact, Szymanski and Zolotor (2001) reported 65% of ADHD cases are connected to some type 
of comorbid condition. This statistic is consistently reported in numerous other studies as well 
(Elliott, 2002; Kanapaux, 2002; Steer, 2005; Voeller, 2004; Wilens, 2006). Elliot (2002) made a 
statement that some suspect ADHD is a precursor for other mental illness, but since ADHD is 
also found in an independent state without other attached illness, this theory was quickly 
rejected.  
Oppositional Defiant Disorder (ODD) most commonly presents in boys with symptoms 
of loss of temper, resentment, and defiant behavior, especially towards authority. Conduct 
Disorder is similar to ODD but is considered more severe with presentations of destructive 
behaviors including harm to others, harm to animals, destroying objects, and/or setting fires. 
When ODD or CD is comorbid with ADHD, patients will not only make poor decisions and/or 
be destructive, but do so impulsively. This may require immediate intervention to avoid harm to 
the patient or others, especially in patients with ADHD and CD. ODD or CD will present in 
approximately 58.5% of ADHD patients according to Weckerly et al. (2004). The same study 
showed 32.7% of their ADHD patients to have anxiety or depression. The Mayo Clinic (2005) 
concurred with similar statistics when noting the prevalence of ODD, CD, depression, and    18 
anxiety with ADHD. Learning disorders also seem to be quite common in ADHD patients, 
requiring the use of special educational services for learning purposes. It is interesting to note 
that Tourette’s syndrome, which manifests with motor or vocal tics, is always present with 
ADHD; however, not all ADHD patients have Tourette’s syndrome (Biederman, Faraone, 
Spencer, et al., 1993).  
Since comorbidity complicates ADHD, most of the literature suggests the best key to 
diagnose ADHD in older, more complicated cases is the presence of inattentiveness and 
hyperactivity early on in the patient’s life. Though this information may be difficult to obtain or 
difficult for older patients to remember, inattentiveness and hyperactivity at an early age are 
typically not present with the comorbidities of ADHD. Another approach to diagnose 
complicated ADHD cases is to treat the comorbidity first, then the symptoms of ADHD should 
be easier to recognize and diagnose if in fact it exists (Elliot, 2002).  
Because of the chronic annoyance of ADHD symptoms, adults with ADHD are at risk to 
develop more comorbidities such as schizophrenia, chemical dependency, antisocial personality 
disorder, mood disorders, and anxiety disorder (Biederman, Faraone, Spencer, et al., 1993). The 
Mayo Clinic (2005) noted the increased risk of chemical dependency, especially alcohol abuse, 
in adult ADHD patients. This may be because substance abuse allows adult ADHD patients with 
poor self-esteem or antisocial tendencies to become more outgoing with others. Another reason 
could be that adult ADHD patients with anxiety or depression become more relaxed and the drug 
use seems to diminish problems or anxieties that the patient may have. Many adult ADHD 
patients may develop cormorbid mental illness because they can not understand or properly 
control their own behavior that leads to long-term frustrations. Adult ADHD patients have been 
shown by the Mayo Clinic (2005) to have higher divorce rates and an increase in marital    19 
stressors when compared to others without ADHD. The same study also showed these patients 
are at higher risk for physical traumas and increased incidence of motor vehicle accidents.  
There are differential diagnoses that can mimic ADHD and/or be comorbid with ADHD. 
Sleep apnea often presents like ADHD because patients will exhibit irritability, inattentiveness, 
and paradoxical hyperactivity due to the lack of sleep (Mayo Clinic, 2005). Bipolar Disorder is a 
complicated illness because it can be a differential diagnosis of ADHD or a comorbid condition 
with ADHD (Montano, 2004). Elliot (2002) goes so far as to suggest the presence of ADHD 
identifies a risk for the patient to later develop Bipolar Disorder. The manic state of Bipolar 
Disorder can appear like ADHD. However, mania patients exhibit short periods of increased 
spending, increased sexual appetite, and/or grandiosity. Patients with ADHD are more likely to 
show longer, more generalized periods of similar mania symptoms such as poor money 
management or procrastination. As mentioned earlier, chemical dependency can be a 
cormorbidity of ADHD, but it can also be a differential diagnosis. Patients often present with a 
history of inattentiveness, monetary problems, and/or increased marital/relationship problems 
that are similar to those of an adult ADHD patient. Montano (2004) suggests one way to rule out 
some of the differentials of ADHD is to use different ADHD rating scales, though there are 
currently no standardized tests available at this time.    
Some medical differentials exist for ADHD as well. These include: hyperthyroidism, 
hypothyroidism, drug interactions, head injury, vitamin B12 deficiency, or heavy metal 
poisoning (Elliot, 2002). However, a complete work-up by a primary care provider should 
clearly rule out most of the medical differential diagnoses of ADHD. If ADHD is likely, an 
MRI/CT or EEG should be done to obtain a baseline for future reference. A neurological and 
mini-mental exam should be performed. Blood pressure and EKG testing should be done if    20 
hypertension or arrhythmia is suspect. Other useful tests to rule out medical conditions are: 
complete blood count, electrolytes, liver function tests, thyroid function tests, vitamin B12 
measurement, and a serum heavy metal screen to rule out poisoning or toxicity (Mayo Clinic, 
2005; Szymanski and Zolotor, 2001). 
Accusations about the Over-Diagnosis of ADHD 
In 1990, 1.6 million cases of ADHD were reported to the CDC; in 1993, 4.2 million cases 
of ADHD were reported (Kanapaux, 2002). When the media began reporting the increase in 
ADHD cases, much speculation arose in the public and among health care providers. ADHD 
became a well-known and popular topic of discussion in America. However, according to 
Kanapaux (2002), ADHD is both over-and under-diagnosed. In fact, it is difficult to find 
evidence that ADHD is over-diagnosed (Jensen et al., 1999). The explanation for the increase in 
new cases during the early 1990’s is because screening tools and the number of school-based 
services increased dramatically (Ellison, 2005), which shed light on the under-diagnosis of 
ADHD at that time. The Surgeon General Report (2001) states that there is a large percentage of 
children across the United States that have a mental illness, yet are not being diagnosed or 
treated due to lack of access to care or lack of community resources. This population includes 
children with ADHD. Research done by the Mayo Clinic (2005) agrees that ADHD is over-and 
under-diagnosed. This article also proposes over-diagnosis occurs in the richer, suburban, 
Caucasian populations due to over-awareness and under-diagnosis/lack of treatment occurs in the 
poorer, rural, African American and Asian populations due to racial bias and/or no insurance 
coverage.       
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Diagnostic Barriers and AAP Treatment Recommendations for ADHD 
  In summary, the evidence has shown that even though there has been much speculation 
about the correct diagnosis of ADHD, it can be diagnosed correctly and in most cases, is being 
correctly diagnosed. ADHD might be under-diagnosed in some cases due to the population of 
children with lack of access to care. The treatment of ADHD has also been scrutinized by media 
and among health care providers. However, it is clearly shown by many sources that multimodal 
treatment is the best approach to manage a patient with ADHD (Szymanski & Zolotor, 2001). 
Multimodal treatment includes pharmacotherapy, behavioral therapy, family involvement, and 
school involvement. However, most PCPs are not following these recommendations because 
they are treating ADHD with stimulant medication alone (Szymanski & Zolotor, 2001).  
  In 2001, The American Academy of Pediatrics (AAP) issued “evidence-based”, clinical 
guidelines for the management of patients diagnosed with ADHD that are still used today and 
regarded as a “framework” of treatment by many of today’s health care providers. The 
statements to follow will outline the AAP’s five recommendations. The first recommendation 
states that PCPs should realize that ADHD is a chronic condition that requires ongoing 
management. The AAP notes that children should receive “child-specific treatment plans… for a 
chronic condition”. This may include: the involvement of other health services, going to ADHD 
support groups with other families, educating families about ADHD and frequently monitoring 
their understanding of the disorder, family counseling, and setting both long and short-term 
treatment goals. These treatment options allow patients and families to build long-term 
relationships with their clinician, other families that have ADHD, and supporting organizations. 
The AAP also suggests that if these relationships are built during management, patients with    22 
ADHD have better outcomes for the entire family, not just the patient with ADHD. Also, patients 
are more satisfied with their treatment and have a better understanding of the disease.  
  The second recommendation by the AAP is that ADHD should be managed with a team 
of people that all have the same goals for the treatment. The American Academy of Family 
Physicians also supports the idea of a multidisciplinary approach to treat ADHD patients 
(Zolotor & Szymanski, 2001).  The interdisciplinary team should include the primary care 
provider, the parents of the child, the child, persons from the child’s school, and other outside 
counselors or organizations involved. The rationale for group collaboration is that ADHD 
manifests in more than one setting in the child’s life. Therefore people involved with the child in 
different settings must be included in the management for consistency purposes. The AAP states 
that a team management approach demonstrates the following results: better relationships with 
family members and others, less manifested symptoms, better results in schoolwork and better 
self-esteem.  
  The third AAP recommendation involves the use of stimulant medication with or without 
behavioral therapy. It is important to note that due to the high efficacy the AAP specifically 
recommends stimulant medication and not some of the alternative medications that are available 
for the treatment of ADHD. According to this study, 80% of children with ADHD respond well 
to stimulant medication (AAP, 2001). Though it is known that behavioral therapy alone is not as 
effective as the use of stimulant medication alone, treatment is enhanced when the two are used 
together (AAP, 2001). For example, a type of behavioral therapy is a rewards system for good 
behavior to encourage a child to make good decisions. Behavioral therapy also builds good 
communication skills among family members to aid in avoiding potential conflict. Another 
advantage of behavioral therapy is setting short term goals to help a child focus and learn the    23 
importance of goals while providing structure to the child. Most importantly, behavioral therapy 
teaches the patient and family how to overcome the difficulties of ADHD symptoms.  
  The forth recommendation from the AAP addresses the concerns of differential diagnosis 
when treatment goals are not being met. As discussed earlier, other disorders can mimic ADHD 
and if treatment is not working as expected, the original diagnosis of ADHD should be re-
evaluated or it should be questioned if a coexisting diagnosis is present. This should only be 
considered after two or three stimulant medications have been tried with the appropriate 
adjunctive therapy and have not been successful (Szymanski and Zolotor, 2001). Additionally, 
the PCP should obtain information about the patient from several sources to rule out incorrect 
information or compliance issues. Treatment goals should be re-evaluated to ensure they are 
realistic. Once these issues are addressed and there is still no response to the treatment regimen, a 
coexisting illness or new diagnosis is probably suspect. This requires re-evaluation of old 
information obtained when the initial diagnosis was made and a new evaluation by a specialist 
such as a developmental-behavioral pediatrician or child psychiatrist. 
  The last recommendation from the AAP addresses the need for consistent and frequent 
follow-up office visits to monitor the progress of the patient. Since stimulant medication often 
requires titration, follow-up visits are obviously mandated until the appropriate dosing is 
obtained. Even after correct dosing is established follow-up visits are also needed to monitor the 
patient’s family dynamics and address any concerns, continue patient education, ensure 
compliance of the treatment regimen, and make new goals for the patient as they grow and 
change. Continuous performance testing may also be used at follow-up visits to demonstrate 
progress in treatment according to Zolotor and Szymanski (2001).             
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Overview of the Stimulant Medications Used to Treat ADHD 
Stimulant medication is the first line of treatment for ADHD because multiple reviews 
and studies have shown that stimulants are efficacious against the main symptoms of ADHD 
(AAP, 2001). Kanapaux (2002) also agreed that stimulants are safe and very effective for the 
first line treatment of ADHD. The stimulants most likely to be used are methylphenidates, 
available in short, intermediate, and long-acting forms or amphetamines, also available in short, 
intermediate, and long-acting forms. The AAP (2001) states “stimulants not only decrease the 
symptoms of ADHD, but improves the child’s ability to develop relationships with peers, 
teachers, and parents”.  
Szymanski & Zolotor (2001) warn that even though stimulants work effectively it is 
important to beware of “rebound effect” when using stimulants. This manifests when drug levels 
fall below the therapeutic range and as a side effect, worsening of the presenting ADHD 
symptoms occurs. In the same article, Szymanski & Zolotor further state this rebound effect 
determines whether or not a patient can be treated with multiple doses of the medication. Other 
than the rebound effect, stimulants are relatively safe with few contraindications. An exception, 
which the Physician’s Desk Reference (2003) warns against, is putting ADHD patient’s with 
seizure disorders on methylphenidate. If other side effects do occur, most are transient and mild 
in nature (Szymanski & Zolotor, 2001). Examples of these side effects are decreased appetite, 
stomachache, headache, delayed sleep, jitteriness, and social withdrawal. The Mayo Clinic 
(2005) states the most common side effects of stimulant medication are loss of appetite, 
decreased sleep, and nervousness. Serious side effects include psychotic reactions, mood 
disturbances, or hallucinations; however, these side effects are rare. The same research showed    25 
that 15-30% of ADHD patients on stimulants will develop motion tics, but as stated before these 
are transient in nature.  
Some have speculated that stimulants cause a delay in the growth of a child. However 
Davis (2005) states there is no evidence to support this side effect of stimulant medication. 
Another theory by some PCP’s is the need for a “holiday period” for patients on long term use of 
stimulants. Syzmanski & Zolotor (2002) state tolerance to stimulant medication does not occur in 
children with ADHD. The Mayo Clinic (2005) states there is no addiction risk to stimulants 
because the drug levels rise in the brain too slowly to create a high. There is no evidence to 
suggest a benefit of stopping stimulant medication for a brief period of time during treatment 
with long term use of stimulants for ADHD patients (Davis, 2005).  
To begin an ADHD patient on stimulant medication, the dose is not based on weight.  
The dose is started at a low level and then titrated up accordingly (Physician’s Desk Reference, 
2003). Stated in the same recommendations, dosing can be increased depending on the time of 
day or the upcoming activities that the patients will attend. This allows patients to have more 
control during certain times of the day when symptoms manifest the most. Szymanski & Zolotor 
(2001) recommend initial dosing to occur once daily and observe the patient’s reaction to the 
medication. Then, the dose can be adjusted or increased as needed for better control. The effects 
of the stimulant medication should be monitored for one or two months of use. If there is still no 
response to the stimulant medication after the dose has been titrated up over this time period, 
then a decision to change stimulants can be made. ADHD patients on stimulant medication do 
not require serologic, hematological, or EKG testing. Once an ADHD patient is started and 
adjusted on a stimulant medication, 80% of the children respond with control of symptoms. Of 
the remaining 20% that did not respond well, those patients should be tried on a different    26 
stimulant medication and are likely to have a good outcome (Szymanski & Zolotor, 2001). If 
there is still not a good response to the medication after three stimulants have failed, the 
diagnosis should be re-evaluated. 
     There are different approaches when choosing which types of stimulant to prescribe an 
ADHD patient. Szymanski & Zolotor (2001) recommend starting an ADHD patient on a rapid 
onset, short duration stimulant. This recommendation was made based on the theory that if a 
child exhibits initial side effects from the stimulant, the medication will cycle through the body 
and be gone quickly. Furthermore, if the stimulant is successful in controlling the symptoms of 
ADHD, it is easier to determine this success by observation of the child on and off the 
medication. However, the recommendation warns that rapid onset, short duration stimulants are 
likely to exhibit the rebound effect due to the multiple doses that are required for good control of 
ADHD symptoms. Both of the stimulants, Methylphenidate and Dextroamphetamine, are 
available in rapid onset, short acting forms and the duration of action of these drugs last 
approximately one to four or five hours (AAP, 2001). Methylphenidate works by blocking the 
activity of dopamine transporters, which are responsible for removing dopamine after it have 
been release at the synapse (Mayo Clinic, 2005).  
Szymanski and Zolotor (2001) do not recommend the use of a slow onset, longer duration 
stimulant as a mono-pharmacotherapy. Slow onset, longer duration stimulant are best used in 
combination with the rapid onset, short duration stimulants. With this recommendation, there is 
coverage over a long period of time and extra control during certain periods of the day when 
symptoms manifest the worst. One such combination is a rapid onset, longer duration stimulant 
which seems to provide excellent control among ADHD patients (Szymanski and Zolotor, 2001). 
An example of this type of medication is Adderall® (Amphetamine-dextroamphetamine) or    27 
Concerta® (Methylphenidate). Adderall XR® was removed from the market in 2005 by the FDA 
due to sudden deaths caused by the medication (Mayo Clinic, 2005).     
Alternative Pharmacotherapy for the Management of ADHD 
  The AAP (2001) only recognizes two other medications for the approved second line of 
treatment in ADHD, tricyclic antidepressants (TCAs) and bupropion. This study also mentions 
the use of clonidine, the antihypertensive medication, to treat ADHD in children that have sleep 
disturbances; however, this is not a prevalent method of treatment. Szymanski and Zolotor 
(2001) suggest the best combination of medications for the treatment of ADHD includes 
medicines that will require few re-doses, will have a fast, predictable onset as well as a long 
duration of action with as few side effects as possible. This study mentions that the use of other 
types of medications, even though considered a second line of treatment for ADHD, may be 
incorporated with stimulants to achieve this effect. Another suggestion from this article was the 
use of antidepressants when ADHD patients have other comorbidities. For example, 
antidepressants affecting norepinephrine levels can be used alone or as adjunctive therapy. 
However, they are also useful when trying to improve patients sleep. A selective serotonin 
reuptake inhibitor would also be an option when a patient with ADHD has depression. As 
mentioned above clonidine has been used due to its effect on modifying emotions and behaviors 
that tend to worsen with stimulants. Other alternative treatments for ADHD mentioned by 
Szymanski and Zolotor (2001) include carbamazepine, divalproex, and risperdal for patients with 
the comorbidity of oppositional defiant disorder. Alternative non-pharmalogical therapies 
include biofeedback, strict diet regimens and dietary supplements, none of which are 
recommended as a main treatment regimen for ADHD patients (Mayo Clinic, 2005). 
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The Prevalence of ADHD into Adulthood 
  Up to 60% of children with ADHD will see the progression of this disease into adulthood 
(Elliott, 2002). Accordingly, the DSM-IV requires a diagnosis of ADHD in childhood in order to 
meet the criteria to diagnose ADHD in adulthood. However, it must be mentioned that not all 
children with ADHD are diagnosed correctly, which means they will fail to meet the diagnostic 
criteria for ADHD as adults. Symptoms of adult ADHD are described very similarly to those in 
the DSM-IV for children—some examples include; inattentiveness, impulsiveness, and/or 
restlessness. The most disconcerting aspect of adult ADHD is the tendency for comorbidities to 
occur in about 40-50% of patients. These include such problems as a high probability of 
substance abuse, bipolar disease, antisocial behavior disorders, and anxiety (Elliott, 2002; 
Montano, 2004). Other problems mentioned by Elliott include the difficulty that an adult with 
ADHD has to achieve higher education. Though it is not the ability to learn that is stunted by the 
disease, but the ability to focus and prioritize tasks necessary for learning. Also, adults with 
ADHD have difficulty maintaining relationships and are more likely to go through divorce. 
Because of problems with attention and completing tasks, adults with ADHD are more likely to 
lose their jobs due to poor performance. It is no wonder that many adults with ADHD develop 
depression due to these socioeconomic stressors. Psychosocial treatments for adults with ADHD 
were developed to address these unique problems (Safren, Sprich, Chulvick, and Otto, 2004). 
This article addressed the tendency for adults with ADHD to go through many failures in life and 
begin to develop a pessimistic outlook. The goal for their research was to develop programs to 
help adults with ADHD remain positive through education about the disease and coping skills. 
The use of support groups were also mentioned to reveal to patients that many adults with    29 
ADHD go through similar experiences and should have certain expectations because of their 
disease.      
Importance of Behavioral Therapy in the Multimodal Management of ADHD 
  There are several reasons why behavioral therapy is an important aspect of the 
multimodal treatment of ADHD and should not be overlooked. An article by Steer (2005) made 
two important statements regarding behavioral therapy in the treatment of ADHD. The first is 
that behavioral therapy was shown to decrease the core symptoms in ADHD and some symptoms 
in ODD. Though medication also decreases the core symptoms of ADHD, behavioral therapy 
does so by a different mechanism of action therefore enhancing the effect of the stimulant. 
Secondly, behavioral therapy provides coverage for the time when stimulants are at sub-
therapeutic levels until the next scheduled dose. Currently there is no stimulant medication 
available that is continuously effective for 24 hours a day and behavioral therapy can bridge that 
gap.  Safren (2004) had two different reasons for the importance of behavioral therapy: 1) 
Behavioral therapy teaches patients the importance of organizational and attentive skills. 2) 
Behavioral therapy teaches children and parents to recognize positive behavioral patterns and 
avoid negative behavioral patterns. Medication alone can not accomplish those two concepts, not 
to mention organizational and attentive skills are invaluable skills for any person to master. 
Szymanski and Zolotor (2001) argue a disease, such as ADHD, that is defined in a set of 
behavioral terms should at least include a treatment regimen with a behavioral aspect to it. 
Furthermore, behavioral goals should be established in the treatment plan that addresses the 
patient’s problematic behaviors. These goals should be achieved with medication and behavioral 
therapy together.    30 
Another study compared behavioral therapy alone, stimulant therapy alone, and 
combined the two treatments as necessary (Dopfner, 2004). If the treatments were effective 
alone, no combination was needed. The results indicated 82% of children started on a stimulant 
medication needed behavioral therapy to be added onto their treatment regimen in order to obtain 
successful management. There is no doubt the standard of treatment for ADHD should at least be 
stimulant medication and behavioral therapy. However, in the past there was speculation about 
the effectiveness of behavioral therapy. In 1993, Swanson et al. stated in their article “… (others 
recommend) stimulants should always be used in combination with educational and behavioral 
interventions, but we found few references to empirical studies to support his common-sense 
recommendation”. Later in the same article in the next to the last sentence, a disclaimer is 
offered stating “…major methodological weaknesses or shortcomings in research preclude clear 
answers to questions about the impact of combined treatment on children with ADD”. An 
adequate amount of current research has since been done to rebuke the statements made in that 
1993 article. Questions still exist as to which of the two (medication or behavioral therapy) is 
more effective alone. But many studies agree both have a synergistic effect when combined 
(Dopfner, 2004; Steer, 2005; Szymanski & Zolotor, 2001; Voeller, 2004).        
Barriers and Negative Attitudes Which Exist in the Treatment of ADHD 
Stein (2004) suggests negative attitudes exist towards the entire field of psychiatry that 
prevents PCPs from referring patients to psychiatrists. Adeyemi, Olonade, and Amira (2002) 
suggest some additional barriers exist that prevent PCPs referrals to psychiatrists. For example, 
lack of insurance coverage or decreased access to psychiatrists might persuade PCPs not to refer 
their patients to a psychiatrist. Another possibility is that PCPs have a lack of knowledge about 
the treatment of ADHD. The study went on to conclude that regardless of the barriers,    31 
physicians’ attitudes toward psychiatry need to be explored further and the barriers need to be 
broken so patients can receive the much needed care from the mental health system. If there is 
bias that exists towards the field of psychiatry from primary care physicians, this could be very 
detrimental to patients (Chadda, 2001). Chadda’s study uncovered that many clinicians 
underestimate the comorbidities of various mental illnesses and therefore do not feel a referral is 
necessary, when indeed it is. This may occur even though a physician is in favor of mental health 
services. Therefore it was suggested that it is not the barriers to mental health that is the problem, 
it is that many clinicians do not fully understand the implications of many mental illnesses and 
consequently do not pursue psychiatric resources that are available (Chadda, 2001). A study 
conducted in Singapore disputes Chadda’s theory. Kua, Parker, Lee, and Jorm (2000) compared 
views about mental health intervention in three prominent psychiatric conditions between PCP’s 
and psychiatrists. Their results indicated that PCP’s held more negative views for the outcome of 
a patient’s health after the mental health intervention than did the psychiatrists, which held 
optimistic outcomes. These pessimistic views toward mental health interventions may be 
explained in Garralda’s study (2001) which found that PCPs have inadequate training in mental 
health. Because of this lack of knowledge, negative views may develop instead of forming a 
view based on fact. This study concluded that better education in mental health is needed for 
PCP’s as well as the development of psychiatric liaisons. Also, it was recommended that 
protocols be developed that PCPs can use as an aid when presented with a patient who has a 
mental illness. Hoagwood, Kelleher, Feil, and Comer (2000) agreed and also found that PCPs 
were less likely to use psychiatric referrals and offer mental health counseling than pediatrician’s 
or psychiatrists. Their study also suggested that there may be a lack of mental health training for    32 
PCPs and offered the idea that maybe there are not enough incentives available for PCPs to refer 
patients to mental health specialties.  
With all of the blame on the PCPs for the lack of mental health referrals, it must be 
mentioned that psychiatrists should push insurance companies more, to secure reimbursement for 
their services (Kanapaux, 2002). This study goes on further to discuss that the efforts to offer 
behavioral therapy to ADHD patients must be a team effort, whereas both the PCP and 
psychiatrist aim to develop better liaisons among themselves. No one side can be to blame, both 
sides must work together to develop better methods of offering mental health services to patients 
that need it. This was shown in 2004 by a pilot study done by Rockman, Salach, Gotlib, et al. In 
their study, they developed a program to initiate liaisons between PCPs and psychiatrists. This 
was done because certain urban and rural areas had decreased access to mental health care 
facilities. After the liaisons were built, results proved that mental health care was enhanced. This 
study shows that mental health care can be established even in areas that lack resources. 
Furthermore, this study implies that it is the lack of planning and unwillingness of clinicians to 
collaborate that is the true barrier at hand. 
Summary and Conclusions 
  Although ADHD has been around since the 1800’s and has been proven to be a 
legitimate neuro-psychiatric disease state, possibly stemming from an imbalance of chemicals in 
the brain, there are still negative perceptions among the public and health care professionals 
towards this disease. Symptoms of ADHD seem subjective; however, they are predictable and 
measurable by the DSM-IV.  Therefore, an accurate diagnosis can be obtained, provided the 
assessment is done by a qualified health care professional that is familiar with the diagnostic 
guidelines. In fact, most PCPs are diagnosing this disease correctly, although this might be due to    33 
an average of over-and-under diagnoses. There are obviously flaws that prevent PCPs from 
diagnosing and treating ADHD correctly. For example, there are many disease that mimic 
ADHD or are comorbid with ADHD. 
  The AAP put out recommended treatment guidelines for ADHD. Studies show that PCPs 
know these guideline, yet are not utilizing them in their ADHD treatment plans. PCPs are most 
likely to prescribe medication alone, when it is recommended by the AAP and many other 
literature sources that a behavioral therapy component should be included. Stimulant medication 
does work well in controlling the core symptoms of ADHD. However, behavioral therapy 
provides a means to control symptoms when the medication is below the therapeutic level as 
well as improve relationships with family and school performance. It is important to obtain an 
appropriate balance of medications and behavioral therapy to control the symptoms of ADHD 
early on in childhood. This will stunt the symptoms of adult ADHD, which can devastate all 
aspects of a patient’s life including the workplace, social life, intimate relationships, self-esteem, 
self-image, and even the health of the patient. The problem that this study wishes to explore is 
the fact that research shows behavioral therapy is not being incorporated into the treatment plans 
of ADHD patients. Therefore, recommendations are not being followed. Although some barriers 
and explanations exist as to why recommendations are not being followed, studies have also 
shown that with the extra initiative of some researchers, these barriers can be overcome. This 
project questioned family practice physicians and psychiatrist about their attitudes and 
knowledge toward behavioral therapy in the treatment of ADHD and seeks to find out what 
barriers are preventing children from receiving the best possible care for an illness that is not 
curable, but treatable.  
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CHAPTER III   
Methodology 
Purpose 
The purpose of this study was to examine and compare the attitudes and knowledge about 
behavioral therapy in the treatment of ADHD between family practice physicians and 
psychiatrists. This chapter will address the design of this study, the hypothesis on which this 
study is based, the study participants, the research questions of this study, the tools used for data 
collection, the validity of this study, and the techniques used to collect and analyze the data.  
Design and Variables 
  Following the Scientific Method, a non-experimental design was used to compare two 
groups of health care professionals, family practice physicians and psychiatrists. This sample of 
participants filled out a questionnaire that consisted of multiple choice questions regarding the 
treatment of ADHD (the independent variable). Data was then obtained from returned 
questionnaires regarding the attitudes and knowledge about behavioral therapy in the treatment 
of ADHD (the dependent variable). There was no control group, random assignment, or 
treatment applied in this study.   
Hypotheses 
   Alternative: Psychiatrists will be more knowledgeable and have a more positive attitude 
toward the use of behavioral treatment for ADHD patients than family practice physicians. 
  Null: There will be no difference in attitude or knowledge about behavioral therapy in the 
treatment of ADHD patients between family practice physicians and psychiatrists.  
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Population and Sample 
  A one-hundred and sixteen subject, cluster sample revolving around the Northwest Ohio 
region was randomly selected to participate in this study from the population of family practice 
physicians and psychiatrists associated with the Medical University of Ohio. Out of the one-
hundred and sixteen subjects, sixty-two were family practice physicians and fifty-four were 
psychiatrists. 
Protection of Participants 
  The Medical University of Ohio granted approval to do this research study and exempt 
status was granted through the Institutional Review Board. Permission to distribute surveys to 
family practice physicians and psychiatrists involved with the Medical University of Ohio was 
granted as well. Each participant in this study received a letter of consent (Appendix A) attached 
to each three-page survey (Appendix B) which explained the purpose of this research. Any 
associated risks were described to participants and participants were informed that their 
participation in this study was completely voluntary and anonymous.   
Research Questions 
1.  What are the gender and age demographics of the study participants? 
2.  How many years have the participants been in clinical practice? 
3.  What type medical specialty and setting do the participants practice in? 
4.   Do the participants manage the treatment of children with ADHD in their 
practice setting? 
5.  Do the participants know the current standard of care for patient with ADHD 
according to the AAP?    36 
6.  Regardless of their knowledge about the treatment of ADHD, how do the 
participants realistically manage children with ADHD in their practice setting? 
7.  Do the participants know what percentage of children will demonstrate ADHD 
symptoms into adulthood? 
8.  Do the participants know the complications associated with ADHD? 
9.  Do the participants know how often patients with ADHD should have follow up 
care? 
10. Are the participants concerned about the stimulant medications they are 
prescribing to children with ADHD? 
11. Regardless of the participants view on stimulant medication, do parents of 
children with ADHD demand medication to control their children? 
12. Do participants value behavioral therapy as a component of treatment for a patient 
with ADHD? 
13. Are the participants utilizing referrals to mental health care facilities for patients 
with ADHD? 
14. What barriers prevent participants from using a mental health care referral? 
15. Is there a significant difference between participants’ knowledge about the 
treatment of ADHD and what they realistically do in their practice setting? 
 Instrumentation and Procedure 
Using a multiple-choice questionnaire, surveys were randomly hand-delivered to a total 
of sixty-two family practice physicians and fifty-four psychiatrists associated with the Medical 
University of Ohio currently practicing in the Northwest Ohio region. These surveys were four 
pages long, each containing a one page letter of informed consent and limited information about    37 
the project as well as three pages containing nineteen multiple-choice survey questions 
(Appendix A, Appendix B). Surveys were distributed in October, 2005 and again in January, 
2006. Data from returned surveys were collected via mail until March 1, 2006. Participants 
received a stamped and addressed envelope in which they were to return the questionnaire 
anonymously through the US Postal Service to the Medical University of Ohio for further 
assessment and analysis. Participants were informed that their participation was voluntary and 
completely anonymous with the statement, “please do not place any identifying names, notes, 
comments, or other information on this questionnaire”. Participants were also verbally informed 
when the surveys were delivered to only complete this survey one time throughout the time 
period of October 2005 until March 2006. Forty-one out of the one hundred and sixteen 
participants returned the completed surveys by mail to the Medical University of Ohio.  
  The initial five questions of the surveys contained demographic data such as gender, age, 
number of years in practice, medical specialty, and type of office setting. The next seven 
questions (questions numbered six through twelve) dealt with the participants’ knowledge about 
treatment of ADHD. These questions were derived from various literature sources written about 
the treatment of ADHD, including recommendations from The American Academy of Pediatrics, 
which is considered to be the standard of care for the treatment of ADHD. Question #6 asked the 
participants if they managed the treatment of ADHD patients. Responses included the options 
yes or no. Question #7 asked respondents to identify the current standard of care option for 
ADHD. Responses included the options: stimulant medication alone, tricyclic antidepressant 
medication (TCAs) alone, behavioral therapy alone, stimulant medication and behavioral 
therapy, or TCA’s and behavioral therapy. The correct choice for this question was the answer 
“stimulant medication and behavioral therapy”. The distracters were based on treatment options    38 
that have been documented in literature, but were not recommended by the AAP as the first line 
of treatment or the standard of care for ADHD. Question #8 was based on the realistic treatment 
regimen that respondents use in their practice. Responses included the options: stimulant 
medication alone, behavioral therapy alone, stimulant and behavioral therapy, non-stimulant 
medication, or no treatment. This question was derived with question #7 to compare if 
respondents realistically practice what they perceived the standard of care for ADHD to be. 
Question #9 asked respondents to identify the percentage of children that demonstrate symptoms 
of ADHD into adulthood. Responses were based on the range of less than twenty percent up to 
one hundred percent. The correct answer to this question was the answer range forty to sixty 
percent. Although, some literature stated there is incidence as high as sixty-five percent; 
therefore the next range, sixty to eighty percent, was also accepted as a correct response. 
Question #10 asked respondents to identify a distracter that is not a common complication 
associated with ADHD. Response options included: rejection from peer groups, symptoms are 
likely to resolve with time, substance abuse, continued disruptive behaviors, and 
academic/employment failure. The correct response was the answer symptoms are likely to 
resolve with time, this is a false statement. All of the other responses are considered common 
complications associated with ADHD. Question #11 asked respondents to identify the distracter 
which was not a side effect of stimulant medication used in the treatment of ADHD. Response 
options included: long-term addiction to the medication, sleep disruption, decreased appetite, 
exacerbation of anxiety, or weight loss. The correct response was long-term addiction to the 
medication, which is not a known side effect caused by stimulant medications used to treat 
ADHD. All of the other responses were valid side effects of stimulant medication used to treat 
ADHD. Question #12 asked respondents to identify how often patients with ADHD should    39 
follow up with their primary care provider, assuming a correct diagnosis of ADHD was made 
and treatment with medication has been successful. Response options included ranges varying 
from once a month to once per year. An option stating follow up is not needed was also given. 
The correct response was three to five times per year.  
  The next seven questions were created to explore attitudes and perceptions towards 
ADHD. Question #13 asked respondents if they are concerned about prescribing stimulant 
medication to children in the management of ADHD. Responses options included the choices 
yes, no, or not sure. The following question, #14, asked respondents if they feel parents of 
children with ADHD demand medication to manage their children, even when the respondent did 
not recommend or discuss medication with the parent. Responses options included the choices 
yes, no, not sure, or not applicable. Question #15 asked respondents if they feel behavioral 
therapy is a necessary component to manage children with ADHD. Response options includes 
the choices yes, no, or not sure.  
  The last four questions of the survey were divided dependent on the respondent’s medical 
specialty. Question #16 and #17 were meant for only family practice physicians to answer. 
Likewise, question #18 and #19 were meant for only psychiatrist to answer. These grouped 
questions were similar in nature and still pertained to the exploration of attitudes and perceptions 
about ADHD. The family practice physicians were asked how often they utilize a referral for 
behavioral therapy on a patient diagnosed with ADHD. Response options included, almost 
always, sometimes, rarely, or never. Similarly, the psychiatrists in question #18 were asked what 
percentage of ADHD patients should receive a referral from their family practice physicians to 
their office for behavioral therapy. Response options included percentages that ranged from less 
than twenty percent to one hundred percent. Question #17 asked family practice physicians what    40 
barriers prevented them from using a referral for mental health purposes. Response options 
included lack of need for extra intervention, mental health services were not available, lack of 
insurance coverage, or not sure of the effectiveness offered by mental health referrals. The 
family practice physicians were asked to mark all of the answers that applied. A similar question 
was asked to the psychiatrists in question #19. The question asked psychiatrists what barriers 
they believe prevent family practice physicians from referring their patients to their practice for 
help with mental health. Response options were the same as given to the family practice 
physicians in question #17. Psychiatrists were to mark all the responses that were applicable. 
  Some of the respondents answered all four questions #16-19, instead of answering only 
the questions that pertained to their medical specialty, as the directions stated. In this instance, 
only the responses in their medical specialty were used in analysis.  
Data Analysis 
All data were entered and analyzed for significant results by using descriptive and 
inferential statistics.  Data was analyzed using SPSS 11.5 and Excel for Windows software. The 
Fisher Exact Test determined statically significant results from the data using an alpha level of 
0.05. Results of the data are explained in Chapter IV of this study.           
Internal and External Validity 
Because of the nature of the non-experimental design, there was no way of establishing a 
cause-and-effect relationship in this study. Only observations, inferences, and comparisons 
between the two different groups were analyzed. Therefore, since no control group or treatment 
existed, internal validity was not a relevant factor in this study. 
 External validity was encouraged by equally, hand-delivering the surveys so there was 
equal accessibility to all participants. Also, external validity was maintained by limiting the    41 
information available to the participants about the nature and objectives of the study. However, 
the Hawthorne effect might have occurred due to the fact that questions involving the knowledge 
of the gold standard of the treatment of ADHD and questions pertaining to the participants 
realistic treatment of ADHD were both present on the survey. Respondents might have been 
persuaded to mark these questions with similar answers, so their knowledge and actions seem 
consistent; instead of what they realistically might carry out as a treatment in their office setting.  
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CHAPTER IV 
Results 
  Of the 116 surveys distributed, 41 participants correctly filled out the surveys and 
returned the survey by mail. Therefore, the response rate from the participants as a whole was 
35%. Of the 62 family practice physicians surveyed, 24 responded for a response rate of 38%. Of 
the 54 psychiatrist surveyed, 17 responded for a response rate of 31%. 
Demographic Data 
Research Question 1 
  The majority of the subjects were male (see Figure 1) and the most prevalent age group 
was between 36-45 years of age. There were no participants over the age of 65 years; however, 
all other age groups were well represented (see Figure 2). 
Females
39%
Males
61%
 
Figure 1. Gender distribution of the participants. 
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Participants were grouped by age clusters; 25 to 35, 36 to 45, 46 to 55, 56 to 65, and over 65 
years of age. 
Age 46-55
29%
Age 36-45
34%
Age 25-35
22%
Age 56-65
15%
. 
Figure 2. Age distribution of the participants. 
Research Question 2 
Participants were asked to disclose the number of years they have been in clinical 
practice (see Figure 3). The majority of the participants have been in clinical practice for over 10 
years.  
>10 years
39%
6-10 years
24%
1-5 years
27%
<1 year
10%
 
Figure 3. Number of years in practice by the participants.    44 
  Research Question 3 
  59% of the participants were family practice physicians and 41% of participants were 
psychiatrists (see Figure 4). Most of the participants were in an academic type of setting, 14 
(34%). None of the participants practiced in a Community Clinic setting or a Private/Single 
setting. 
Psychiatrist
41%
Family Practice
59%
 
Figure 4. The medical specialties of the participants. 
Findings 
Research Question 4 
  Participants were asked if they take part in the management of ADHD patients. 80% of 
the participants admitted they manage the treatment of ADHD patients, while 17% stated they 
did not. One participant left all of the options blank and did not answer this question.  When the 
participants were divided into their medical specialties, all of the family practice physicians 
(FPs) responded that they do manage the treatment of ADHD patients; while only 53% of the 
psychiatrists (PSY) reportedly managed patients with ADHD (see Figure 5).    45 
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Figure 5. By specialty, the number of participants that manage ADHD patients. 
Research Question 5 
  The participants were asked to recognize the AAP treatment guidelines for ADHD among 
various distracters. 85% of all the respondents recognized the correct response of “stimulant 
medication and behavioral therapy (Stimulant & BxTx)”. The most frequent incorrect answer 
was the option, “stimulant medication alone”; which was selected by 10% of all participants. By 
medical specialty, 92% of family practice physicians answered this question correctly, while 
only 76% of psychiatrists chose the correct response (see Figure 6). None of the participants 
selected the options that included tricyclic antidepressants (TCAs). A comparison using the 
Fisher Exact test was done between family practice physicians and psychiatrists regarding their 
knowledge about the treatment of ADHD. Results were not statistically significant; therefore, it 
can be deducted that there is no significant difference in the knowledge about treatment of 
ADHD between family practice physicians and psychiatrists.     46 
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Figure 6. Participants’ identification of the ideal treatment option for ADHD patients. 
 Research Question 6 
  Regardless of their knowledge about the treatment of ADHD, participants were asked to 
mark the treatment option they would most likely carry out in their practice. Family practice 
physicians were most likely to recommend stimulant medication and behavioral therapy to their 
ADHD patients at 63%; while the other 38% chose to use stimulant medication alone (see Figure 
7). None of the family practice physicians chose tricyclic antidepressants, behavioral therapy 
alone, or no treatment as their management of an ADHD patient. Psychiatrists were also most 
likely to recommend stimulant medication and behavioral therapy at 65%. None of the 
psychiatrists chose the option “no treatment”.  
    47 
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Figure 7. Participants’ realistic treatment options for ADHD patients. 
Research Question 7 
  Participants were asked to identify the percentage range of children that will demonstrate 
ADHD symptoms into adulthood. The most frequent answer among all participants was the 
range 20-40% (see Figure 8). 54% of the participants chose this option, which was incorrect. By 
specialty, 46% of family practice physicians and 65% of psychiatrists chose the range 20-40%. 
In actuality, about 40-60% of children with ADHD will go into adulthood with this disease. Only 
20% of the participants recognized the correct response; by specialty, this included 25% of 
family practice physicians and 12% of psychiatrists. None of the psychiatrists selected the 
extreme percentage ranges of less than 20% or greater than 80%. Family practice physicians 
selected a wide variety of answers (see Figure 8). A comparison using the Fisher Exact test 
between the medical specialties was performed. Results were not statistically significant; 
therefore, it can be deducted that there was no statistical significance between the medical 
specialties regarding knowledge about the progression of ADHD into adulthood.     48 
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Figure 8. Participants’ identification of the percentage range of children with ADHD that have 
progression of ADHD into adulthood. 
Research Question 8 
  Participants were asked to identify a list of complications of ADHD and select the option 
which was not a complication. 83% of participants were able to do this correctly and identified 
the distracter, which is not a complication of ADHD, “symptoms are likely to resolve with time”. 
The most common missed response by the participants at 12% was the option, “rejection from 
peer groups”, which is a common complication with ADHD. All of the participants correctly 
recognized the options “substance abuse” and “academic/employment” as common 
complications of ADHD (see Figure 9). All of the family practice physicians correctly 
recognized the option “continued disruptive behaviors” as a common complication of ADHD.  
A comparison using the Fisher Exact test was done between the medical specialties. Results were 
not statistically significant; which indicates there is no statistically significant difference in the 
participants’ identification of ADHD complications between the two medical specialties.     49 
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Figure 9. Participants’ identification of complications not associated with ADHD. 
Research Question 9 
  Participants were asked to identify the recommended number of follow-up visits a patient 
with ADHD should have, assuming a medication regimen has already been established. The 
majority of the participants (61%) recognized the correct range of 3-5 times per year (see Figure 
10). The most common incorrect answer by the participants was the option 1-3 times per year, 
which was the selection of 27% of participants. None of the participants answered the choices, 
“once per year…” or “follow-up is not needed”. A comparison using the Fisher Exact test 
between the medical specialties was performed. The results were not statistically significant; 
therefore, it can be deducted that there is no statistically significant difference in the participants’ 
knowledge about the number of follow-up visits a patient with ADHD should have between the 
two medical specialties.          50 
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Figure 10. Participants’ identification of the appropriate number of follow-up visits needed for 
ADHD patients. 
Research Question 10 
  Participants were asked if they are concerned about prescribing stimulant medication to 
children with ADHD. 56% of participants stated they were not concerned about prescribing 
stimulants to children with ADHD. 2% of participants were ambivalent and chose the response 
“not sure”. Though the majority of participants was not concerned; among the family practice 
physicians, 54% stated they were concerned about prescribing stimulants to children with ADHD 
(see Figure 11). This is compared to the 18% of psychiatrists that answered they too had 
concerns. A comparison using the Fisher Exact test between the medical specialties was 
performed. Results indicated a statistically significant difference between the two medical 
specialties (p=0.043). This can be interpreted that there is a statistically significant difference    51 
between family practice physicians and psychiatrist when prescribing stimulant medication to 
children with ADHD. Furthermore, family practice physicians are statistically more concerned 
about prescribing stimulants to children with ADHD than are psychiatrists. 
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Figure 11. Number of participants that are concerned about prescribing stimulants to children 
with ADHD 
Research Question 11 
  Participants were asked if they felt the parents of children with ADHD demand 
medication for their children when in the office. Answers among the participants were varied. 
The highest percentage of participants (46%) felt that parents do demand medication for their 
children with ADHD. However 10% of participants answered “not sure” and 7% answered “not 
applicable”. Among the family practice physicians, 58% agreed that parents do indeed demand 
medication when in their office. Psychiatrists were more varied in their responses, with 18% 
stating this question was not applicable (see Figure 12). A comparison using the Fisher Exact test 
between the medical specialties was performed. Results indicated there is no statistically    52 
significant difference (p=0.058) between the two medical specialties; therefore, both family 
practice physicians and psychiatrists generally feel that some parents do indeed demand 
medication for their child with ADHD.  
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Figure 12. Participants’ responses as to whether they feel parents demand stimulant medication 
for their children with ADHD. 
Research Question 12 
  Participants were asked if they felt behavioral therapy is a necessary component in the 
treatment of ADHD. A majority of the participants agreed that behavioral therapy is necessary to 
treat ADHD (see Figure 13). However, 10% of participants responded that they were not sure 
whether or not it is necessary. 17% of family practice physicians disagreed, and answered that 
they felt behavioral therapy is not necessary in the treatment plan. This opposes the psychiatrists 
view, because none answered that behavioral therapy is not a necessary component of treatment. 
Nonetheless, 24% of psychiatrists did mark the choice, “not sure”. A comparison using the 
Fisher Exact test was done to note if there was a significant difference between the two medical    53 
specialties. Results did not indicate significant results. An interpretation can therefore be made 
that there is no significant difference in attitudes towards the importance of behavioral therapy in 
the treatment of ADHD between psychiatrists and family practice physicians.     
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Figure 13. Participants’ views when asked if behavioral therapy is a necessary component in the 
treatment of ADHD.  
Research Question 13 
  Family practice physicians were asked how often they utilize a mental health referral in 
order for a child with ADHD to receive behavioral therapy. 42% of family practice physicians 
answered that a referral for the mental health services is almost always used when treating a 
child with ADHD (see Figure 14). Only 21% admitted using these referrals rarely and only if the 
patient case is extreme. None of the physicians marked the answer, “never, there is no need for 
extra intervention”.  
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Figure 14. Family practice physicians’ utilization of mental health referrals for ADHD patients. 
  Alternatively, psychiatrists were asked what percentage of ADHD patients should receive 
a referral for mental health care purposes. 46% of psychiatrists answered that family practice 
physicians should give a mental health care referral for an ADHD patient in about 40-60% of the 
cases (see Figure 15). Only 24% of psychiatrists thought a referral is necessary in greater than 
80% of ADHD cases. 
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Figure 15. Psychiatrists’ perceptions about the percentage of ADHD patients that should receive 
mental health referral.      55 
Research Question 14 
  Participants were questioned as to what barriers exist that prevent family practice 
physicians from utilizing a referral for mental health purposes in general. As noted in Figure 16, 
the highest percentage (33%) of family practice physicians responded that a lack of insurance 
coverage for mental health care is the major barrier that prevents them from utilizing a referral. 
However, there were a variety of responses, including combinations of responses.   
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Figure 16. Barriers that prevent family practice physicians from using mental healthcare. 
  Similarly, psychiatrists were asked what barriers they think prevent family practice 
physicians from utilizing mental health care referrals. Again, a wide variety and combination of 
responses were gathered in the data and expressed in Figure 17. Psychiatrists as a group did not 
seem to favor one particular barrier, which indicates that there are many barriers that 
psychiatrists think prevent family practice physicians from utilizing a mental health care referral.  
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 Figure 17. Psychiatrist perceptions of barriers that prevent family practice physicians from 
utilizing a mental health care referral. 
Research Question 15 
  A comparison using the Fisher Exact test between the participants’ knowledge about the 
treatment of ADHD and the realistic treatment plan that participants carry out in their practice 
was performed. The results of this were statistically significant and can be interpreted that 
participants know the correct AAP treatment guidelines; however, in their practice setting they 
are more likely to treat ADHD with medication alone. When these variables were compared 
between the medical specialties, no significant results were indicated. Therefore, a conclusion 
can be made that there is no statistically significant difference between the knowledge about the 
treatment of ADHD and the actual treatments given in the clinical settings between family 
practice physicians and psychiatrist. Both specialties known the treatment guidelines, but are 
treating patients with ADHD with stimulant medication alone.     
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CHAPTER V 
 
Discussion 
  This chapter will summarize and discuss the findings of this research study. From the 
findings of this research, conclusions can be implied and inferences may be drawn. The 
recommendations for further research will be addressed in this discussion. This chapter will draw 
conclusions as to the important findings that this study has uncovered related to the initial 
problem statement and hypotheses.    
Findings 
Demographic Research Questions 1-3 
  The gender and age demographics were well distributed in this study. The majority of the 
participants were male; however, it is common knowledge that the field of medicine tends to be a 
male dominated field. Therefore, it is not surprising that 61% of the participants were male. The 
age demographics were equally distributed among this sample of participants. There were no 
participants over the age of 65 years, which was expected considering many adults do not work 
past the age of 65. The fact that only 21% of the participants were in the age range of 25 to 35 
years of age is reassuring to this study. This is because all participants were associated with the 
Medical University of Ohio, which houses many students. It could be speculated if the youngest 
age range was the majority that some of the participants made students or residents working with 
them take the survey, instead of the intended participant. However, this does not seem to be the 
case based on the distributed of ages stated by the participants. 
  The distribution of the participants’ years of experience in the clinical setting was 
reassuring. The results indicated an equal variety of clinical experience among the participants. 
This again, suggests that participants did not push students or residents to complete the survey    58 
for the intended participant. The highest percentage of participants had been in practice for over 
10 years. This could play an interesting role in the biases and attitudes towards ADHD. This is 
because ten years ago ADHD was viewed in a very different way than it is today. As mentioned 
in the literature, ADHD was put in a negative light in the 1990’s by the media and negative 
perceptions about the disease evolved (Kanapaux, 2002). Participants that practiced in the 1990’s 
might still hold on to some of those misperceptions about ADHD. 
  The demographic data containing the medical specialty of the participants was imperative 
for this research because this research aims to compare family practice physicians and 
psychiatrists’ responses to the survey. Obviously, without knowing the medical specialty of the 
participants, comparisons between the two groups could not be performed. The type of setting 
that the participants practiced in was also important. Since the highest percentage of participants 
practice in an academic type of setting (34%), it could be assumed that those participants should 
be the most aware of the guidelines in the literature regarding ADHD. People in academic 
settings are often responsible for teaching others and may keep up with current trends in ADHD 
treatment better than those in other settings, where there is less pressure to stay involved with 
current literature.  
Research Question 4 
  It was important for this study to know if the participants take part in the management of 
ADHD patients. 17% of the respondents stated they do not. Participants that are not involved 
with ADHD patients might know less about the disease and treatment of the disease than those 
who are involved with ADHD patients. It is interesting to note that all of the family practice 
respondents deal with ADHD patients. Therefore, the prevalence of ADHD as the most common 
psychiatric disorder in children is supported by this research study (Szymanski & Zolotor, 2001).    59 
Only 53% of psychiatrists reported managing patients with ADHD. This may be due to the lack 
of referrals to their practice. As literature has documented, many patients with ADHD never see 
a psychiatrist for behavioral therapy (Kanapaux, 2004). The data from this research study 
supports that concept. 
Research Question 5 
             This study found that 85% of the participants identified the correct AAP 
guidelines for the treatment of ADHD. Results from the data also indicated there was no 
difference in knowledge about the treatment of ADHD between family practice physicians and 
psychiatrists. Therefore, it is not the lack of knowledge about the treatment of ADHD that is a 
barrier towards patients receiving optimal care, which supports findings in the literature. It is 
surprising that only 76% of psychiatrists marked the correct treatment regimen. It was expected 
all of the psychiatrists would answer this question correctly due to the nature of their field and 
expertise in behavioral therapy. None of the participants answered responses including tricyclic 
antidepressants. This is promising, considering tricyclic antidepressants are considered as second 
or third line of therapy, or are used when an ADHD patient have a comorbid condition (AAP, 
2001). Data from this study suggests that all participants clearly recognized tricyclic 
antidepressant as a distracter and not part of the gold standard of care for ADHD patients.  
Research Question 6, 12, & 15 
    Recognizing that most of the participants are aware of the AAP treatments guidelines, it 
is surprising to find participants that do not follow these guidelines. For example 38% of family 
practice physicians treat their ADHD patients with stimulant medication alone. Dopfner (2004) 
did a study in which 82% of the children on stimulant medication alone ended up needing a 
behavioral therapy component added to the treatment regimen in order to achieve successful    60 
management. Without underestimating the participants that do not follow treatment guidelines, it 
is reassuring that most of the participants do chose to follow the AAP guidelines in their practice 
when managing children with ADHD. Additionally participants admit the importance of 
incorporating behavioral therapy into their treatment plans. 
Research Question 7 
  40-60% of children with ADHD will see progression of the disease into adulthood 
(Elliott, 2002). Percentages above 60% were noted by other sources; however, these sources 
were not found in reliable literature. In a disease that devastates many different aspects of a 
patient’s life, it becomes of the utmost importance to get symptoms of this disease under control 
early on. If a clinician is not aware of the prevalence of this disease into adulthood, they may fail 
to realize the possible comorbidities and disdain the patient will undergo in the future. It is well 
known that physicians in general are not aware of the serious comorbities that encompass many 
mental illnesses (Chadda, 2001). Data from this study supports that theory. 80% of the 
participants in this study were not aware of the percentage of progression of ADHD into 
adulthood. That is alarming when the implications are considered. Not only were participants 
unaware of the correct percentage, but most of the incorrect responses underestimated the 
percentage. Also surprising, was the percentage of psychiatrists that answered incorrectly (88%). 
This was not expected due to the nature of the profession, especially when dealing with chronic 
mental illnesses. Such an overwhelming statistic could mean that the question was written 
poorly. If data from this sample of participants is reflective of the healthcare population, more 
education is needed to inform health care providers of the prevalence of ADHD into adulthood. 
Possibly, if healthcare providers were more aware of the progression of ADHD into adulthood,    61 
more aggressive treatment regimens would be implemented, including behavioral therapy 
component. 
Research Question 8 
           In general participants in this study seemed able to recognize the complications 
associated with ADHD. 83% of participants were able to identify a distracter that was not a 
complication with ADHD. There are many complications with ADHD, as well as many 
comorbidities. It is important that healthcare professionals are able to recognize the 
complications of ADHD, so the treatment plan can be develop and adjusted accordingly. It is 
also worth repeating the fact that there is currently no lab work that tests for ADHD. ADHD is a 
disease that manifests in behavioral terms and therefore requires attentive observation in 
different settings to fully understand and treat it appropriately.  
Research Question 9 
  In general, participants were able to correctly identify the recommended follow up 
schedule after a medication regimen has been implemented. This was encouraging considering 
Stockl, Hughes, Jarrar, Secnik, & Perwien (2003) found that adequate follow up is essential for 
the success of the treatment of ADHD. The results from this research question were not expected 
because of literature that states most children with ADHD do not receive adequate follow up 
(Rushton, Fant, & Clark, 2004). Furthermore, none of the participants chose responses at the 
lower range such as, “once per year” or “no follow-up is needed”. This indicates that participants 
are aware that frequent follow up is an important aspect when treating ADHD.  
Research Question 10 & 11 
  To begin this section, it must be noted that the use of stimulant medication for children 
has brought up many complicated issues. In the 1990’s there was fear among healthcare    62 
providers when prescribing schedule II drugs to children (Kanapaux, 2002). Such unfounded 
fears may still exist in health care professionals that have been in practice for greater than 10 
years. This theory was discussed in the demographic findings as well. On the opposite side, some 
feel that parents of children with ADHD often demand medications to control their children with 
ADHD, even in cases where medication may not be indicated (Elliott, 2002). In summary, health 
providers have fears toward stimulant medication, while patients are demanding it. To further 
complicate matters there are many myths about the use of stimulants such as; stimulants are 
easily abuse, stimulants will stunt a child’s growth, “drug holidays” are needed, etc. Regardless 
of the myths, the AAP (2001) and Szymanski and Zolotor (2001) strongly support the use of 
stimulants in the treatment of ADHD and document that stimulants are very safe for children to 
use. With the current literature noted, participants in this study still expressed significant fear in 
prescribing stimulants to children (54%), especially among the family practice physicians when 
compared to psychiatrists ( p=0.043). Psychiatrists did not have significant results and therefore 
do not seem to be fearful when prescribing stimulants to children with ADHD. Speculation 
suggests maybe psychiatrists are more knowledgeable when using medications in mental 
illnesses.  
  Also interesting in the data is that 58% of family physicians feel parents of children 
demand medication for their children with ADHD. This could be compared to the common 
knowledge that some patients see a physician when they are sick and demand an antibiotic, even 
when the illness is probably viral. Out of frustration, the physician gives the patient the 
antibiotic.  In the same sense, it could be inferred that parents demand stimulants to control their 
children, even when a proper evaluation and diagnosis for ADHD may have not occurred. If the 
physician gives the patient a low dose of stimulation medication out of frustration, this could    63 
explain why no behavioral therapy is incorporated into this “treatment plan”. However, this 
theory is purely speculation from the data.     
Research Question 13 &14 
  The data from this research shows a wide distribution of responses when family practice 
physicians were asked how often they utilize referrals for children with ADHD. It seems that a 
referral for behavioral therapy for patient with ADHD might be done on a case-by-case basis 
among family practice physicians; instead of as a standard protocol in the treatment plan. This 
inference is based on the logic that if you are likely do a referral for behavioral therapy for one 
patient with ADHD, and the literature supports the use of behavioral therapy in ADHD, why not 
do it for all the patients with ADHD? If a referral is not being offered to all the patients with 
ADHD, then there is either a barrier that prevents certain patients from receiving a referral or the 
physician does not deem the referral necessary based on the case presentation. 
  The psychiatrists in this study also gave ambivalent responses as to how often a referral 
for behavioral therapy should be utilized in ADHD patients. Results from the previous research 
questions proved that the participants think that behavioral therapy is useful and try to 
incorporate it in the treatment of ADHD patients. The question still remains as to why referrals 
are not used for every ADHD patient. The majority of psychiatrists in the study stated these 
referrals should be used in 40-60% of ADHD cases.  
  The participants in this study gave various responses as to some of the barriers that 
prevent referrals from occurring in the mental health field in general. For example, lack of 
insurance coverage, lack of access to care, or the physician’s indecision of the effectives of the 
service provided. All of which are significant problems that need to be overcome and warrant 
further investigation.     64 
Conclusions 
  In conclusion, there was no significant difference in the knowledge base about the 
treatment of ADHD between family practice physicians and psychiatrists. Also, both medical 
specialties view behavioral therapy as important when treating ADHD. Both medical specialties 
are relatively familiar with the AAP treatment guidelines for ADHD. There was a statistically 
significant difference between family practice physicians and psychiatrists when asked about the 
concerns of prescribing stimulants to children. However, the significance is not the main focus of 
this research study. It should be noted that both medical specialties lack the knowledge about 
ADHD and the occurrence into adulthood. Again, this will just be noted because that is not the 
main focus of this study. Therefore, with these results discussed, the alternative hypothesis, 
“Psychiatrists will be more knowledgeable and have a more positive attitude towards the use of 
behavioral treatment for ADHD patients than family practice physicians”, shall be rejected. 
Likewise, the null hypothesis, “There will be no difference in attitude or knowledge about 
behavioral therapy in the treatment of ADHD patients between family practice physicians and 
psychiatrists”, shall be accepted in this research project.  
Recommendations 
Future studies in the area of ADHD should be conducted in order to offer some relief to 
patients that are not receiving adequate management. Though this research project does not 
address adult ADHD specifically, more research needs to be done regarding health care 
professional’s perceived lack of knowledge in this area. Studies should specifically address how 
health care professionals will prevent the symptoms of ADHD from manifesting in adulthood. 
Furthermore, our healthcare system should expect this disease to be chronic and have longer 
term treatment plans available.     65 
This researcher believes there is still work to be done to break down the negative 
perceptions about mental illness through research. ADHD has had many negative perceptions 
according to the literature, though not seen in this study. Although negative perceptions about 
ADHD have slowly declined over the years, the negative stigma is still present. Studies need to 
be done to convince others in the media and even others in the healthcare field, that mental 
illnesses are debilitating and often chronic conditions that require intense attention and 
aggressive management.  
Finally, ongoing research should be done to break the barriers that prevent primary health 
care providers (PCPs) from utilizing referrals. PCPs are not qualified to deal with mental illness, 
nor should they be. The scope of psychiatry is vast and requires specialization. Therefore 
referrals play an important role when bridging the gap between PCPs and psychiatrists. 
Regardless of the barriers, healthcare providers have an oath to do what is best for the patient 
which means we must find a way through research to break such barriers down. 
Significance for Physician Assistants 
  Similar implications stated in the above recommendation section can be applied to the 
clinical realm. Since the history and core of the physician assistant profession stems from family 
practice, it is fair to state physician assistants (PAs) will deal with ADHD patients in clinical 
practice with regularity. This gives PAs the opportunity to follow ADHD patients on a long-term 
basis and to serve as educators for families and patients with ADHD. With the appropriate care 
and management of these patients by PAs, negative attitudes and bias towards this illness can be 
broken down. Finally, PAs are meant to represent healthcare in a team setting. This mentality 
should serve as bridge to facilitate the much needed contacts with psychiatric referral sources for 
patients with ADHD.      66 
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Appendix A 
 
 
 
 
 
 
 
 
My name is Amy Newman, PA-S. I am a Physician Assistant student at the 
Medical University of Ohio. As part of my graduate education, I am conducting 
this research project in order to better understand the attitudes and knowledge 
about behavioral therapy in the treatment of attention deficit/hyperactivity disorder 
among various health care providers. You are invited to participate in this study 
because of the location and specialty of your health care practice. To participate, 
you will only need to fill out the attached questionnaire. There will be complete 
privacy of the information you supply because your name will never be used or 
associated with the project. You are free to choose to participate or not participate, 
and you may stop your participation at any time. Whether you participate or not 
will have no detrimental effect on your career as a health care provider. 
Completing and returning this questionnaire indicates that you agree to take part in 
this research. Please do not place any identifying names, notes, comments, or other 
information on this questionnaire or on the return envelope that is provided for 
you. If you have any questions about this research, please contact Amy Newman, 
PAS at (419) 383-5889. Thank you! 
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The following survey was developed to assess the knowledge and attitudes among 
primary care physicians and psychiatrists regarding the treatment of Attention 
Deficit/Hyperactivity Disorder (ADHD). Your assistance in this academic research 
is greatly appreciated. For the following questions please circle the single best 
answer to the best of your ability. 
 
Demographic and Practice Characteristics 
Questions 1-5 are for demographic and practice characteristic purposes only.  
 
1. What is your gender?  2. What is your age?    3. How long have you 
been 
     A.  Male           A.  25-35          in clinical practice? 
     B.  Female          B.  36-45          A.  < 1year 
             C.  46-55          B.  1-5 yrs 
             D.  56-65          C.  6-10 yrs 
             E.  65+          D.  >10 yrs 
  
4.   What is your medical specialty? 
      A.   Family Practice 
      B.   Psychiatry 
   
5.   What setting do you primarily practice in? 
      A.   Office 
      B.   Hospital 
      C.   Community Clinic 
      D.   Academic 
      E.   Group 
      F.   Private/Single 
 
Knowledge about the treatment of ADHD 
Questions 6-12 are based upon treatment options for ADHD.  
 
6. In your medical specialty do you manage the treatment of children with ADHD? 
 A. Yes 
B. No 
 
7. What is the current standard of care option for ADHD? 
     A.  Stimulant medication alone  
     B.  Tricyclic antidepressant medication alone 
     C.  Behavioral therapy alone 
     D.  Stimulant medication and behavioral therapy 
     E.  Tricyclic antidepressant medication and behavioral therapy 
 
8. When managing a patient diagnosed with ADHD, what regimen would you 
     realistically select for your patient? 
     A.  Stimulant medication alone 
     B.  Behavioral therapy alone 
     C.  Stimulant medication and behavioral therapy 
     D.  Non-stimulant medication  Appendix  B  74 
9.  What percentage of children with ADHD demonstrate symptoms into 
     adolescence/adulthood? 
     A. <20%           B.  20-40%           C.  40-60%           D.  60-80%           E.  80-100% 
 
10. ALL of the following are complications associated with ADHD EXCEPT: 
     A.  Rejection from peer groups 
     B.  Symptoms are likely to resolve with time 
     C.  Substance abuse 
     D.  Continued disruptive behaviors 
     E.  Academic/Employment failure 
 
11. All of the following are side effects of stimulant medication for ADHD EXCEPT? 
     A.  Long-term addiction to the medication 
     B.  Sleep disruption 
     C.  Decreased appetite 
     D.  Exacerbation of anxiety 
     E.  Weight loss 
 
12. How often should patients with ADHD follow-up in your office once a correct diagnosis and 
management with medication has been made? 
     A.  once per month 
     B.  3-5 times per year 
     C.  1-3 times per year 
     D.  once per year to re-evaluate and make appropriate adjustments 
     E.  follow-up is not needed once appropriate management has been established 
 
    
Attitudes and Perception towards the treatment of ADHD 
Questions 13-19 explore attitudes and perceptions toward ADHD. Please answer these questions 
to the best of your knowledge. 
 
13.  Are you concerned about prescribing stimulant medication to children to manage ADHD? 
A.  Yes 
B.  No 
C.  Not sure 
 
14. Do you feel that parents of children diagnosed with ADHD demand medication to manage 
their children even when you do not recommend medication? 
A.  Yes 
B.  No 
C. Not sure 
D. Not applicable 
 
15. Do you feel behavioral therapy is a necessary component to manage ADHD patients? 
A.  Yes 
B.  No 
C.  Not sure 
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Questions 16 & 17 are for family practice physicians only: 
16. How often do you utilize a referral (for behavioral therapy purposes) for a patient 
     diagnosed with ADHD? 
     A.   Almost always, it is part of a complete treatment regime in my practice. 
     B.   Sometimes, referrals are case dependent. 
     C.   Rarely, only in severe patient presentations. 
     D.   Never, there is no need for extra intervention. 
 
17. In general, what barriers prevent you from using referrals for mental health purposes? 
Check all that apply: 
     A.  Lack of need for extra intervention. 
     B.  Mental health services are not available.  
     C.  Lack of insurance coverage for mental health referrals. 
     D.  Not sure of the effectiveness offered by mental health referrals. 
 
Questions 18 & 19 are for Psychiatrist only: 
18. About what percentage of the ADHD patients should receive a referral to your office from 
their family practice physician for behavioral therapy as part of their management. 
     A.   > 80% 
     B.  60-80% 
     C.  40-60% 
     D.  20-40% 
     E.  < 20% 
 
19. In general, what barriers do you think prevent family practice physicians from utilizing 
referrals to your practice? 
Check all that apply: 
     A.  Lack of need for extra intervention. 
     B.  Mental health services are not available.  
     C.  Lack of insurance coverage for mental health referrals. 
     D.  Not sure of the effectiveness offered by mental health referrals. 
 
 
 
 
Thank you for taking time to participation in this survey! Please return this completed 
questionnaire by October 15, 2005 in the self-addressed, stamped envelope provided to: 
Amy Newman 
3000 Arlington Ave 
Toledo, Ohio 43614 
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134241434212111 # # # # # # 1 1 4
12311143221221123 # # # # # #
1211114322421112 1 0 # # # # # #
144242432223231 # # # # # # # # # # # #
124221432211231 # # # # # # 43
221212432413211 # # # # # # 12
122241112211223 # # # # # # 34
13414141311222223 # # # # # #
11214141321211122 # # # # # #
22314143221213118 # # # # # #
2121 1 4 14312411111 1 4 # # # # # #
23311143221222113 # # # # # #
134241434212111 # # # # # # 1 1 4
12411143421322118 # # # # # #
21114141221221123 # # # # # #
133291342212221 # # # # # # 35
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6f
7a + d 0.05
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Objective:  This study explored attitudes and knowledge about behavioral therapy in the 
treatment of attention deficit/hyperactivity disorder (ADHD) between family practice physicians 
(FPs) and psychiatrists. Other topics included adult ADHD, the barriers of mental health 
referrals, and stimulant medication. 
Method:  After IRB approval, multiple-choice surveys were hand-delivered to 116 
participants, including family practice physicians and psychiatrists, in the Northwest Ohio 
region. Surveys were anonymously returned by mail and data was analyzed for significance 
using SPSS. 
Results:  There was no significant statistical difference in the identification of the AAP 
treatment guidelines for ADHD between the two medical specialties. There was also no 
significant statistical difference in the acknowledgement of the importance for behavioral 
therapy in the treatment of ADHD between the two medical specialties. Significant results 
indicated FPs are hesitant to prescribe stimulant medication to children with ADHD. Lastly, it 
was discovered that participants in general did not realize the prevalence of ADHD into 
adulthood.  
Conclusion:  It was found that there was no difference in the attitudes or knowledge 
about behavioral therapy in the treatment of ADHD between FPs and psychiatrists. This study 
agrees with other literature in that clinicians know the correct treatment guidelines for ADHD yet 
are not following them in practice either due to barriers in the systems that prevent mental health 
referrals or other unknown bias.  
 
 